Bolden Therapeutics

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to promote neurogenesis for treating central nervous system illnesses like Alzheimer's disease. They are developing antisense oligonucleotides to modulate a key molecular pathway stimulating neural stem cells. This approach aims to promote the birth of new neurons in the adult brain.

Buy Funded Startups lists

Funding Round: Pre-Seed

Funding Amount: $1.5M

Date: 17-Jan-2024

Investors: Resolute Venture Partners, Slater Technology Fund, Lifespan Vision Ventures, multiple angel investors

Markets: Biotechnology, Therapeutics, Neurogenesis, Biotechnology Research

HQ: Providence, Rhode Island, United States

Founded: 2019

Website: https://www.boldentherapeutics.com/

LinkedIn: https://www.linkedin.com/company/bolden-therapeutics

Twitter:

Instagram: